Intelligencia Raises $12M To Reduce The Risk Of Clinical Research, Improve R&Amp;D Productivity, And Accelerate Scientific Breakthroughs
Amount Raised
$12 Million
Round Type
Funding Round
New YorkInformation TechnologyDescription
Intelligencia, whose AI-driven software platform enables pharmaceutical and biotechnology companies to revolutionize the drug development process and reduce risk, has raised $12M in order to continue to expand its product offering and customer base. Healthtech investor MTIP led the oversubscribed Series A round, joined by several of the company’s existing investors, including Big Pi Ventures and Synetro Group. ZS, a global professional services firm that leverages deep analytics and biopharmaceutical industry expertise to help companies and their customers thrive, has also participated in this round.
Who to call at Intelligencia Inc., and when
A new round usually means Intelligencia Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Intelligencia Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Intelligencia Inc., from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Intelligencia Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Intelligencia Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.